EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Willingness to pay for assisted reproductive technologies among individuals with infertility in China

Chaofan Li iD, Hongbin Cong, Stephen Jan, Lei Si, Ling Geng iD, Shunping Li iD

Health Policy and Planning · 17.09.2025 · 40 (8) · 867-875

DOI: 10.1093/heapol/czaf045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Policy and Planning, online erschienen am 17.07.2025. Verfasst von Chaofan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jin…. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Infertility, Financing, Personal, Health Expenditures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of education of Humanities and Social Science project, Shandong Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infertility, a widely prevalent condition globally, incurs high economic burdens. Assisted reproductive technologies (ARTs) are effective treatments, but public health financing in low- and middle-income countries (LMICs) rarely covers ART services. In China, where birth rates are declining, willingness to pay (WTP) can inform insurance reimbursement policies by reducing out-of-pocket expenses. However, there is no consensus on WTP thresholds for assessing the cost-effectiveness of fertility treatments in LMICs. This study aimed to assess WTP for ART among individuals with infertility in China. Data were obtained from a cross-sectional survey conducted at five hospitals across different geographical and socioeconomic regions in China. Individuals with infertility were recruited using a quota sampling method. A contingent valuation method was employed, with three hypothetical WTP scenarios developed to present detailed information on the success rates, costs, and the treatment processes of in vitro fertilization (IVF), artificial insemination (AI), and preimplantation genetic testing (PGT). A total of 570 individuals with infertility participated in the survey [94.4% female; mean (standard deviation) age: 33.0 (4.7) years]. The sampled respondents were willing to pay renminbi (RMB) 30 163 [$4259, 95% confidence interval (CI): RMB 29 650–30 675] for IVF, RMB 6046 ($854, 95% CI: RMB 5987–6106) for AI, and RMB 47 234 ($6669, 95% CI: RMB 46 435–48 033) for PGT. These WTPs were equivalent to 0.34, 0.07, and 0.53 times the GDP per capita in China, respectively. Older age and male-factor or unexplained infertility were significantly associated with lower WTP (P < .05), while higher education and patient-physician communication about costs were positively associated with WTP (P < .05). These findings suggest that public health insurance schemes should establish appropriate cost-effectiveness thresholds and reimbursement ceilings for ART to improve affordability and access. Incorporating patient-physician communication about cost into clinical practice may facilitate shared decision-making and potentially increase patients’ perceived value of ART.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedInfertilityFinancing, PersonalHealth ExpendituresHumansChinaFemaleAdultCross-Sectional StudiesMaleCost-Benefit AnalysisFertilization in VitroSurveys and Questionnaires

Stichwörter der Autor:innen

health economicspatientswillingness to pay

Autor:innen und Institutionen

  • Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan 250012, China.
  • NHC Key Laboratory of Health Economics and Policy Research (Shandong University), 44 Wenhuaxi Road, Jinan 250012, China.
  • Center for Health Management and Policy Research, Shandong University (Shandong Provincial Key New Think Tank), 44 Wenhuaxi Road, Jinan 250012, China.
  • Center for Health Preference Research, Shandong University, 44 Wenhuaxi Road, Jinan 250012, China.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, 44 Wenhuaxi Road, Jinan 250012, China.
  • The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, 300 Barangaroo Ave, Sydney, NSW 2000, Australia.

ORCID-Profile: Chaofan Li, Ling Geng, Shunping Li

Förderung

  • Ministry of education of Humanities and Social Science project
  • Shandong Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Li, C., Cong, H., Jan, S., Si, L., Geng, L., & Li, S. (2025). Willingness to pay for assisted reproductive technologies among individuals with infertility in China. Health Policy and Planning, 40(8), 867-875. https://doi.org/10.1093/heapol/czaf045

Vancouver

Li C, Cong H, Jan S, Si L, Geng L, Li S. Willingness to pay for assisted reproductive technologies among individuals with infertility in China. Health Policy and Planning. 2025;40(8):867-875. doi:10.1093/heapol/czaf045

BibTeX
@article{Li2025,
  author = {Li, Chaofan and Cong, Hongbin and Jan, Stephen and Si, Lei and Geng, Ling and Li, Shunping},
  title = {Willingness to pay for assisted reproductive technologies among individuals with infertility in China},
  journal = {Health Policy and Planning},
  year = {2025},
  volume = {40},
  number = {8},
  pages = {867--875},
  doi = {10.1093/heapol/czaf045}
}
Kostenlos starten →